Roles of the EZH2 histone methyltransferase in cancer epigenetics - PubMed (original) (raw)

Review

. 2008 Dec 1;647(1-2):21-9.

doi: 10.1016/j.mrfmmm.2008.07.010. Epub 2008 Aug 3.

Affiliations

• PMID: 18723033
• DOI: 10.1016/j.mrfmmm.2008.07.010

Review

Roles of the EZH2 histone methyltransferase in cancer epigenetics

Jeffrey A Simon et al. Mutat Res. 2008.

Abstract

EZH2 is the catalytic subunit of Polycomb repressive complex 2 (PRC2), which is a highly conserved histone methyltransferase that targets lysine-27 of histone H3. This methylated H3-K27 chromatin mark is commonly associated with silencing of differentiation genes in organisms ranging from plants to flies to humans. Studies on human tumors show that EZH2 is frequently over-expressed in a wide variety of cancerous tissue types, including prostate and breast. Although the mechanistic contributions of EZH2 to cancer progression are not yet determined, functional links between EZH2-mediated histone methylation and DNA methylation suggest partnership with the gene silencing machinery implicated in tumor suppressor loss. Here we review the basic molecular biology of EZH2 and the findings that implicate EZH2 in different cancers. We also discuss EZH2 connections to other silencing enzymes, such as DNA methyltransferases and histone deacetylases, and we consider progress on deciphering mechanistic consequences of EZH2 overabundance and its potential roles in tumorigenesis. Finally, we review recent findings that link EZH2 roles in stem cells and cancer, and we consider prospects for integrating EZH2 blockade into strategies for developing epigenetic therapies.

PubMed Disclaimer

Similar articles

• The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing.
  Nuytten M, Beke L, Van Eynde A, Ceulemans H, Beullens M, Van Hummelen P, Fuks F, Bollen M. Nuytten M, et al. Oncogene. 2008 Feb 28;27(10):1449-60. doi: 10.1038/sj.onc.1210774. Epub 2007 Sep 3. Oncogene. 2008. PMID: 17724462
• The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.
  Caretti G, Di Padova M, Micales B, Lyons GE, Sartorelli V. Caretti G, et al. Genes Dev. 2004 Nov 1;18(21):2627-38. doi: 10.1101/gad.1241904. Genes Dev. 2004. PMID: 15520282 Free PMC article.
• Inner workings and regulatory inputs that control Polycomb repressive complex 2.
  O'Meara MM, Simon JA. O'Meara MM, et al. Chromosoma. 2012 Jun;121(3):221-34. doi: 10.1007/s00412-012-0361-1. Epub 2012 Feb 19. Chromosoma. 2012. PMID: 22349693 Free PMC article. Review.
• The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cells.
  Aoki R, Chiba T, Miyagi S, Negishi M, Konuma T, Taniguchi H, Ogawa M, Yokosuka O, Iwama A. Aoki R, et al. J Hepatol. 2010 Jun;52(6):854-63. doi: 10.1016/j.jhep.2010.01.027. Epub 2010 Mar 24. J Hepatol. 2010. PMID: 20395008
• Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2.
  Tsang DP, Cheng AS. Tsang DP, et al. J Gastroenterol Hepatol. 2011 Jan;26(1):19-27. doi: 10.1111/j.1440-1746.2010.06447.x. J Gastroenterol Hepatol. 2011. PMID: 21175789 Review.

Cited by

• miR-23a impairs bone differentiation in osteosarcoma via down-regulation of GJA1.
  Gindin Y, Jiang Y, Francis P, Walker RL, Abaan OD, Zhu YJ, Meltzer PS. Gindin Y, et al. Front Genet. 2015 Jul 2;6:233. doi: 10.3389/fgene.2015.00233. eCollection 2015. Front Genet. 2015. PMID: 26191074 Free PMC article.
• EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors.
  Fillmore CM, Xu C, Desai PT, Berry JM, Rowbotham SP, Lin YJ, Zhang H, Marquez VE, Hammerman PS, Wong KK, Kim CF. Fillmore CM, et al. Nature. 2015 Apr 9;520(7546):239-42. doi: 10.1038/nature14122. Epub 2015 Jan 28. Nature. 2015. PMID: 25629630 Free PMC article.
• Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.
  Atchison M, Basu A, Zaprazna K, Papasani M. Atchison M, et al. Crit Rev Oncog. 2011;16(3-4):143-61. doi: 10.1615/critrevoncog.v16.i3-4.20. Crit Rev Oncog. 2011. PMID: 22248052 Free PMC article. Review.
• Blood-, Tissue- and Urine-Based Prognostic Biomarkers of Upper Tract Urothelial Carcinoma.
  Łaszkiewicz J, Krajewski W, Sójka A, Nowak Ł, Chorbińska J, Subiela JD, Tomczak W, Del Giudice F, Małkiewicz B, Szydełko T. Łaszkiewicz J, et al. Diagnostics (Basel). 2024 Aug 31;14(17):1927. doi: 10.3390/diagnostics14171927. Diagnostics (Basel). 2024. PMID: 39272712 Free PMC article. Review.
• Investigation of epigenetics in kidney cell biology.
  Li LX, Agborbesong E, Zhang L, Li X. Li LX, et al. Methods Cell Biol. 2019;153:255-278. doi: 10.1016/bs.mcb.2019.04.015. Epub 2019 Jun 13. Methods Cell Biol. 2019. PMID: 31395383 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science

• Other Literature Sources

  • The Lens - Patent Citations Database